abnormal heart development_Mdm4<tm1Zmy>/Mdm4<tm1Zmy>

http://metadb.riken.jp/0000267I129C57BL6Mdm4tm1ZmyMdm4tm1ZmyMdm4tm1Zmy

abnormal heart development_Mdm4<tm1Zmy>/Mdm4<tm1Zmy>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transformed mouse 3T3 cell double minute 4
  http://metadb.riken.jp/db/mgi_rdf/MGI:107934

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Mdm4<tm1Zmy>/Mdm4<tm1Zmy>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Mdm4<tm1Zmy>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129 * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal heart development
  http://purl.obolibrary.org/obo/MP_0000267

文献

http://purl.org/net/cito/citesAsAuthority

• Lei. Huang, et.al., The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo., Proceedings of the National Academy of Sciences of the United States of America, 2011, 108
  http://rdf.ncbi.nlm.nih.gov/pubmed/21730163